Investors Capital Advisory Services’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Investors Capital Advisory Services’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,000	Closed	-$14K	–	764
2015 Q3	$14K	Sell	1,000 -500	-33%	-$8.64K	﹤0.01%	712
2015 Q2	$29K	Sell	1,500 -590	-28%	-$11.4K	0.01%	717
2015 Q1	$37K	Buy	2,090 +620	+42%	+$14K	0.01%	714
2014 Q4	$34K	Sell	1,470 -225	-13%	-$5.2K	0.01%	695
2014 Q3	$41K	Buy	1,695 +60	+4%	+$1.56K	0.01%	673
2014 Q2	$45K	Sell	1,635 -60	-4%	-$1.8K	0.01%	678
2014 Q1	$57K	Sell	1,695 -30	-2%	-$1.02K	0.01%	635
2013 Q4	$32K	Buy	1,725 +440	+34%	+$8.01K	0.01%	629
2013 Q3	$20K	Sell	1,285 -675	-34%	-$7.82K	0.01%	591
2013 Q2	$20K	Buy	+1,960	New	+$23K	0.01%	545

Other funds holding CTIC

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Investors Capital Advisory Services's CTIC Position: Q4 2015 in Review

Investors Capital Advisory Services sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2015, closing a stake of 1,000 shares — an estimated $14K sold.

Investors Capital Advisory Services first reported a position in CTIC in Q2 2013 and held it in 10 quarters. The position peaked at $57K in Q1 2014. 94 funds tracked by Wall St. Rank hold CTIC as of Q4 2015.

Investors Capital Advisory Services reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2015 after selling out during the quarter.
Investors Capital Advisory Services sold 1,000 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2015, an estimated $14K.
Investors Capital Advisory Services first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 10 quarters.
Investors Capital Advisory Services's CTI BioPharma Corp. (DE) Common Stock position peaked at $57K in Q1 2014.
94 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2015.

Based on Investors Capital Advisory Services's 13F filing for Q4 2015, filed 8 Feb 2016.